Skip to content

Psychological and physiological benefits of early exercise-based rehabilitation in patients with acute coronary syndrome: a clinical randomized controlled trial

Psychological and physiological benefits of early exercise-based rehabilitation in patients with acute coronary syndrome: a clinical randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072730
Enrollment
Unknown
Registered
2023-06-23
Start date
2021-02-01
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

Early exercise intervention group:The trial group followed an individualized early exercise rehabilitation program that was tailored to each patient's cardiac function and progress in rehabilitation.
Control group:Regular activity guidance

Sponsors

Fujian Provincial Hospital;Shengli Clinical Medical College of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria for the study were as follows: (1) Successful coronary angiography; (2) Age between 18 and 79 years old; (3) Preoperative PHQ-9 score =4. All participants or their legal guardians provided informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: The exclusion criteria for the study were as follows: (1) Severe liver, brain, kidney, digestive, respiratory system diseases, or any other serious systemic illnesses; (2) History of mental illness such as schizophrenia or schizo affective disorder (ICD-10: F20.x or F25.x), or bipolar disorder (ICD-10: F31.x); (3) Patients taking sedative drugs; (4) Presence of cognitive impairment or uncooperativeness; (5) Patients with Parkinson's disease or anxiety disorder; (6) Acute onset of various acute infections, fevers, or other systemic diseases.

Design outcomes

Primary

MeasureTime frame
Depression;troponin I ;N-terminal pro-B-type natriuretic peptide ;Fasting blood glucose;

Secondary

MeasureTime frame
Incidence of constipation;Adverse event rate;Exercise endurance;Self-care ability;

Countries

China

Contacts

Public ContactRehua Wang

Fujian Provincial Hospital;Shengli Clinical Medical College of Fujian Medical University

rehuawang03@163.com+86 136 0089 1808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026